Evidence map›Paper›PMID 34745721›Full record

ArticleBiomedical optics express2021

Monitoring subcutaneous tumors using Mueller polarimetry: study on two types of tumors.

Briséis Varin, Jean Rehbinder, Jean Dellinger, Christian Heinrich, Marc Torzynski, Caroline Spenlé, Dominique Bagnard, Jihad Zallat

Abstract read
In one paragraph

Article in Biomedical optics express, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Briséis VarinICube Laboratory, University of Strasbourg, Bd Sébastien Brant, 67412-Illkirch, France.ORCID https://orcid.org/0000-0003-4740-8938
Jean RehbinderICube Laboratory, University of Strasbourg, Bd Sébastien Brant, 67412-Illkirch, France.ORCID https://orcid.org/0000-0003-3060-8300
Jean DellingerICube Laboratory, University of Strasbourg, Bd Sébastien Brant, 67412-Illkirch, France.
Christian HeinrichICube Laboratory, University of Strasbourg, Bd Sébastien Brant, 67412-Illkirch, France.ORCID https://orcid.org/0000-0002-2988-292X
Marc TorzynskiICube Laboratory, University of Strasbourg, Bd Sébastien Brant, 67412-Illkirch, France.
Caroline SpenléINSERM U1119-Labex Medalis, University of Strasbourg, Bd Sébastien Brant, 67412-Illkirch, France.
Dominique BagnardINSERM U1119-Labex Medalis, University of Strasbourg, Bd Sébastien Brant, 67412-Illkirch, France.
Jihad ZallatICube Laboratory, University of Strasbourg, Bd Sébastien Brant, 67412-Illkirch, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A better understanding of tumor development is crucial for treating cancer. Polarimetric imaging is an interesting alternative for monitoring subcutaneous tumors as it is non-invasive. In this study, a Mueller spectro-polarimeter is used to monitor tumor development on mice injected with non-pigmented breast cancer cells or with pigmented murine melanoma cells. Three stages of non-pigmented tumor development are revealed with three polarimetric parameters. These stages also appear for pigmented tumors, although less clearly. A halo of high depolarization surrounding the non-pigmented tumor in the first stage allows the outlining of the tumor. Considering polarimetric parameters, a biological interpretation is proposed.

Identifiers

PMID34745721
PMCPMC8548010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.